LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 13

Search options

  1. Article ; Online: Potential new treatment strategies for COVID-19: is there a role for bromhexine as add-on therapy?

    Depfenhart, Markus / de Villiers, Danielle / Lemperle, Gottfried / Meyer, Markus / Di Somma, Salvatore

    Internal and emergency medicine

    2020  Volume 15, Issue 5, Page(s) 801–812

    Abstract: Of huge importance now is to provide a fast, cost-effective, safe, and immediately available pharmaceutical solution to curb the rapid global spread of SARS-CoV-2. Recent publications on SARS-CoV-2 have brought attention to the possible benefit of ... ...

    Abstract Of huge importance now is to provide a fast, cost-effective, safe, and immediately available pharmaceutical solution to curb the rapid global spread of SARS-CoV-2. Recent publications on SARS-CoV-2 have brought attention to the possible benefit of chloroquine in the treatment of patients infected by SARS-CoV-2. Whether chloroquine can treat SARS-CoV-2 alone and also work as a prophylactic is doubtful. An effective prophylactic medication to prevent viral entry has to contain, at least, either a protease inhibitor or a competitive virus ACE2-binding inhibitor. Using bromhexine at a dosage that selectively inhibits TMPRSS2 and, in so doing, inhibits TMPRSS2-specific viral entry is likely to be effective against SARS-CoV-2. We propose the use of bromhexine as a prophylactic and treatment. We encourage the scientific community to assess bromhexine clinically as a prophylactic and curative treatment. If proven to be effective, this would allow a rapid, accessible, and cost-effective application worldwide.
    MeSH term(s) Betacoronavirus ; Bromhexine/therapeutic use ; COVID-19 ; Coronavirus Infections/drug therapy ; Expectorants/therapeutic use ; Humans ; Pandemics ; Pneumonia, Viral/drug therapy ; SARS-CoV-2 ; Serine Endopeptidases/drug effects ; Virus Internalization/drug effects
    Chemical Substances Expectorants ; Serine Endopeptidases (EC 3.4.21.-) ; TMPRSS2 protein, human (EC 3.4.21.-) ; Bromhexine (Q1J152VB1P)
    Keywords covid19
    Language English
    Publishing date 2020-05-26
    Publishing country Italy
    Document type Journal Article ; Review
    ZDB-ID 2454173-4
    ISSN 1970-9366 ; 1828-0447
    ISSN (online) 1970-9366
    ISSN 1828-0447
    DOI 10.1007/s11739-020-02383-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Indonesian medical frontliners during the coronavirus disease 2019 pandemic: Have we been protecting them enough?

    Lazarus, Gilbert / Meyer, Markus / Depfenhart, Markus / Tjahjadi, Angela Kimberly / Dewayanti, Santi Rahayu / Dakota, Iwan / Siswanto, Bambang Budi

    Journal of clinical and translational research

    2021  Volume 7, Issue 4, Page(s) 558–562

    Abstract: Background and aim: The coronavirus disease 2019 pandemic has brought deteriorating physical and mental burdens to health care workers (HCWs) in Indonesia, mainly attributed to the lack of protection and screening among HCWs, patients' concealment of ... ...

    Abstract Background and aim: The coronavirus disease 2019 pandemic has brought deteriorating physical and mental burdens to health care workers (HCWs) in Indonesia, mainly attributed to the lack of protection and screening among HCWs, patients' concealment of their travel and medical history, and perceived social stigma and discrimination. Hence, we deliver our perspectives and recommendations based on the current situation in Indonesia to enforce their safeties. We encourage stakeholders to implement a systematic approach by employing stringent prevention strategies, ensuring adequate personal protective equipment (PPE) provision and equitable PPE distribution, and routine HCWs screening to prevent nosocomial clusters, in addition to the provision of psychosocial support to HCWs by offering social aids and psychological sessions. Furthermore, social stigma and discrimination toward HCWs and patients should also be addressed and mitigated, thus preventing concealments of patients' history and alleviating emotional burdens. We believe that providing continuous support to HCWs would lead to key benefits in ensuring a winning battle against the COVID-19 pandemic.
    Relevance for patients: HCWs are pivotal players in winning the battle against the COVID- 19 pandemic. Ensuring their safety and well-being will enable them to deliver better healthcare services, thus resulting in mutual benefit for themselves, the patients, and the nation's recovery.
    Language English
    Publishing date 2021-07-30
    Publishing country Singapore
    Document type Journal Article ; Review
    ZDB-ID 3019815-X
    ISSN 2424-810X ; 2382-6533
    ISSN (online) 2424-810X
    ISSN 2382-6533
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Oxygen-ozone (O

    Franzini, Marianno / Valdenassi, Luigi / Ricevuti, Giovanni / Chirumbolo, Salvatore / Depfenhart, Markus / Bertossi, Dario / Tirelli, Umberto

    International immunopharmacology

    2020  Volume 88, Page(s) 106879

    Abstract: Objective: This study evaluated the potential efficacy of a novel approach to treat COVID-19 patients, using an oxygen-ozone (O: Results: Following O: Conclusion: Our results show that ... ...

    Abstract Objective: This study evaluated the potential efficacy of a novel approach to treat COVID-19 patients, using an oxygen-ozone (O
    Results: Following O
    Conclusion: Our results show that O
    MeSH term(s) Aged ; Betacoronavirus ; Blood Gas Analysis ; COVID-19 ; Coronavirus Infections/immunology ; Coronavirus Infections/therapy ; Humans ; Immunotherapy/instrumentation ; Immunotherapy/methods ; Infusions, Intravenous ; Intensive Care Units ; Oxygen/administration & dosage ; Oxygen/therapeutic use ; Ozone/administration & dosage ; Ozone/therapeutic use ; Pandemics ; Pneumonia, Viral/immunology ; Pneumonia, Viral/therapy ; Respiration, Artificial ; Respiratory Distress Syndrome/immunology ; Respiratory Distress Syndrome/therapy ; SARS-CoV-2 ; Treatment Outcome
    Chemical Substances Ozone (66H7ZZK23N) ; Oxygen (S88TT14065)
    Keywords covid19
    Language English
    Publishing date 2020-08-08
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2043785-7
    ISSN 1878-1705 ; 1567-5769
    ISSN (online) 1878-1705
    ISSN 1567-5769
    DOI 10.1016/j.intimp.2020.106879
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Potential new treatment strategies for COVID-19

    Depfenhart, Markus / de Villiers, Danielle / Lemperle, Gottfried / Meyer, Markus / Di Somma, Salvatore

    Internal and Emergency Medicine

    is there a role for bromhexine as add-on therapy?

    2020  Volume 15, Issue 5, Page(s) 801–812

    Keywords Internal Medicine ; Emergency Medicine ; covid19
    Language English
    Publisher Springer Science and Business Media LLC
    Publishing country us
    Document type Article ; Online
    ZDB-ID 2454173-4
    ISSN 1970-9366 ; 1828-0447
    ISSN (online) 1970-9366
    ISSN 1828-0447
    DOI 10.1007/s11739-020-02383-3
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article: Potential new treatment strategies for COVID-19: is there a role for bromhexine as add-on therapy?

    Depfenhart, Markus / de Villiers, Danielle / Lemperle, Gottfried / Meyer, Markus / Di Somma, Salvatore

    Intern Emerg Med

    Abstract: Of huge importance now is to provide a fast, cost-effective, safe, and immediately available pharmaceutical solution to curb the rapid global spread of SARS-CoV-2. Recent publications on SARS-CoV-2 have brought attention to the possible benefit of ... ...

    Abstract Of huge importance now is to provide a fast, cost-effective, safe, and immediately available pharmaceutical solution to curb the rapid global spread of SARS-CoV-2. Recent publications on SARS-CoV-2 have brought attention to the possible benefit of chloroquine in the treatment of patients infected by SARS-CoV-2. Whether chloroquine can treat SARS-CoV-2 alone and also work as a prophylactic is doubtful. An effective prophylactic medication to prevent viral entry has to contain, at least, either a protease inhibitor or a competitive virus ACE2-binding inhibitor. Using bromhexine at a dosage that selectively inhibits TMPRSS2 and, in so doing, inhibits TMPRSS2-specific viral entry is likely to be effective against SARS-CoV-2. We propose the use of bromhexine as a prophylactic and treatment. We encourage the scientific community to assess bromhexine clinically as a prophylactic and curative treatment. If proven to be effective, this would allow a rapid, accessible, and cost-effective application worldwide.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #378214
    Database COVID19

    Kategorien

  6. Article ; Online: Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported

    Franzini, Marianno / Valdenassi, Luigi / Ricevuti, Giovanni / Chirumbolo, Salvatore / Depfenhart, Markus / Bertossi, Dario / Tirelli, Umberto

    International Immunopharmacology

    2020  Volume 88, Page(s) 106879

    Keywords Immunology ; Immunology and Allergy ; Pharmacology ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ZDB-ID 2043785-7
    ISSN 1567-5769
    ISSN 1567-5769
    DOI 10.1016/j.intimp.2020.106879
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Book ; Online ; Thesis: Schlafqualität als Prädiktor für die Schwere des Entzugs bei Alkoholikern

    Depfenhart, Markus

    2006  

    Author's details vorgelegt von Markus Depfenhart
    Language German
    Size Online-Ressource
    Document type Book ; Online ; Thesis
    Thesis / German Habilitation thesis Univ., Diss--Frankfurt (Main), 2006
    Note Erscheinungsjahr an der Haupttitelstelle: 2005
    Database Former special subject collection: coastal and deep sea fishing

    More links

    Kategorien

  8. Article: Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported

    Franzini, Marianno / Valdenassi, Luigi / Ricevuti, Giovanni / Chirumbolo, Salvatore / Depfenhart, Markus / Bertossi, Dario / Tirelli, Umberto

    Int Immunopharmacol

    Abstract: OBJECTIVE: This study evaluated the potential efficacy of a novel approach to treat COVID-19 patients, using an oxygen-ozone (O2-O3) mixture, via a process called Oxygen-Ozone- Immunoceutical Therapy. The methodology met the criteria of a novel, ... ...

    Abstract OBJECTIVE: This study evaluated the potential efficacy of a novel approach to treat COVID-19 patients, using an oxygen-ozone (O2-O3) mixture, via a process called Oxygen-Ozone- Immunoceutical Therapy. The methodology met the criteria of a novel, promising approach to treat successfully elderly COVID-19 patients, particularly when hospitalized in intensive care units (ICUs) Experimental design: We investigated the therapeutic effect of 4 cycles of O2-O3 in 50 hospitalized COVID-19 subjects suffering from acute respiratory disease syndrome (ARDS), aged more than 60 years, all males and undergoing non invasive mechanical ventilation in ICUs. RESULTS: Following O2-O3 treatment a significant improvement in inflammation and oxygenation indexes occurred rapidly and within the first 9 days after the treatment, despite the expected 14-20 days. A significant reduction of inflammatory and thromboembolic markers (CRP, IL-6, D-dimer) was observed. Furthermore, amelioration in the major respiratory indexes, such as respiratory and gas exchange markers (SatO2%, PaO2/FiO2 ratio), was reported. CONCLUSION: Our results show that O2-O3 treatment would be a promising therapy for COVID-19 patients. It leads patients to a fast recovery from ARDS via the improvement of major respiratory indexes and blood gas parameters, following a relatively short time of dispensed forced ventilation (about one to two weeks). This study may encourage the scientific community to further investigate and evaluate the proposed method for the treatment of COVID-19 patients.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #695657
    Database COVID19

    Kategorien

  9. Article ; Online: Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported

    Franzini, Marianno / Valdenassi, Luigi / Ricevuti, Giovanni / Chirumbolo, Salvatore / Depfenhart, Markus / Bertossi, Dario / Tirelli, Umberto

    2020  

    Abstract: Objective: This study evaluated the potential efficacy of a novel approach to treat COVID-19 patients, using an oxygen-ozone (O2-O3) mixture, via a process called Oxygen-Ozone- Immunoceutical Therapy. The methodology met the criteria of a novel, ... ...

    Abstract Objective: This study evaluated the potential efficacy of a novel approach to treat COVID-19 patients, using an oxygen-ozone (O2-O3) mixture, via a process called Oxygen-Ozone- Immunoceutical Therapy. The methodology met the criteria of a novel, promising approach to treat successfully elderly COVID-19 patients, particularly when hospitalized in intensive care units (ICUs) Experimental design: We investigated the therapeutic effect of 4 cycles of O2-O3 in 50 hospitalized COVID-19 subjects suffering from acute respiratory disease syndrome (ARDS), aged more than 60 years, all males and undergoing non invasive mechanical ventilation in ICUs. Results: Following O2-O3 treatment a significant improvement in inflammation and oxygenation indexes occurred rapidly and within the first 9 days after the treatment, despite the expected 14-20 days. A significant reduction of inflammatory and thromboembolic markers (CRP, IL-6, D-dimer) was observed. Furthermore, amelioration in the major respiratory indexes, such as respiratory and gas exchange markers (SatO2%, PaO2/FiO2 ratio), was reported. Conclusion: Our results show that O2-O3 treatment would be a promising therapy for COVID-19 patients. It leads patients to a fast recovery from ARDS via the improvement of major respiratory indexes and blood gas parameters, following a relatively short time of dispensed forced ventilation (about one to two weeks). This study may encourage the scientific community to further investigate and evaluate the proposed method for the treatment of COVID-19 patients.
    Keywords COVID-19 ; covid19
    Subject code 610
    Language English
    Publishing country it
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Book ; Online ; Thesis: Schlafqualität als Prädiktor für die Schwere des Entzugs bei Alkoholikern

    Depfenhart, Markus [Verfasser]

    2006  

    Author's details vorgelegt von Markus Depfenhart
    Keywords Medizin, Gesundheit ; Medicine, Health
    Subject code sg610
    Document type Book ; Online ; Thesis
    Database Digital theses on the web

    More links

    Kategorien

To top